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Post-Exercise Assessment of Cardiac
Repolarization Alternans in Patients With Coronary
Artery Disease Using the Modified Moving Average Method
Michael P. Slawnych, MD, PHD,* Tuomo Nieminen, MD, PHD,† Mika Kähönen, MD, PHD,‡††
Katherine M. Kavanagh, MD,* Terho Lehtimäki, MD, PHD,§¶ Darlene Ramadan, RN,*
Jari Viik, PHD,‡‡ Sandeep G. Aggarwal, MD,* Rami Lehtinen, PHD,‡††§§ Linda Ellis, BSC,*
Kjell Nikus, MD,** Derek V. Exner, MD, MPH,* for the REFINE (Risk Estimation Following
Infarction Noninvasive Evaluation) and FINCAVAS (Finnish Cardiovascular Study) Investigators
Calgary, Alberta, Canada; and Tampere and Lahti, Finland
Objectives We sought to evaluate the utility of T-wave alternans (TWA) assessment in the immediate post-exercise period to
identify and validate cutpoints for the modified moving average (MMA) assessment method.
Background The presence of TWA is associated with an increased risk of cardiovascular death (CVD). The immediate post-
exercise period, where increased physiologic stress and minimal surface artifact coexist, appears ideal to imple-
ment the MMA method.
Methods A test (n  322) and validation cohort (n  681) provided 1,003 patients with coronary artery disease (CAD).
We assessed TWA immediately after exercise. The outcomes, CVD and mortality, were adjudicated independent
of the TWA results.
Results During 48 months of follow-up 85 deaths, 54 categorized as CVD (64%), were observed. A linear relationship
between the magnitude of TWA and the risk of CVD was identified. As a continuous measure TWA voltage was
equivalent to ejection fraction in predicting the risk of CVD. To facilitate clinical application, a sensitive, modest
predictive accuracy (20 V) and a specific, greater predictive accuracy MMA cutpoint (60 V) were identified and
validated. Each cutpoint was associated with a 2.5-fold greater risk of CVD, independent of other important vari-
ables, including ejection fraction.
Conclusions Post-exercise assessment of TWA using the MMA method is a strong, independent predictor of risk in patients
with CAD. The 20-V cutpoint (87% sensitivity) appears to be most suitable in higher-risk patients, whereas the
60-V cutpoint (95% specificity) appears more appropriate when TWA is used as a single screening test in those
at lower risk. (Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a
Heart Attack; NCT00399503) (J Am Coll Cardiol 2009;53:1130–7) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.12.026c
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March 31, 2009:1130–7 Post-Exercise Repolarization Alternans Assessmentond solely relying on a low EF are required. The assess-
ent of dynamic changes in cardiac repolarization has been
dvocated for this purpose. Visible beat-to-beat alterations
n cardiac repolarization, or T-wave alternans (TWA), have
een reported in patients with ischemia, inherited primary
lectrical disorders, and electrolyte imbalances (4–6). The
resence of lower-amplitude TWA also has been indepen-
ently associated with an increased risk of serious outcomes
7–11). Multiple approaches of assessing TWA have been
escribed (12) but 2 methods, the spectral (8,10,13–16) and
he modified moving average (MMA) methods (1,11,17,18),
ave been best studied. Both predict an independently greater
isk of serious outcomes.
This analysis sought to further evaluate the utility of
WA assessment in the immediate post-exercise period,
ith a goal of identifying and validating cut-off values for
WA by use of the MMA method. An important objective
f this analysis was to identify MMA cutpoints that could
e used in future studies.
ethods
ohorts. Descriptions of the REFINE (Risk Estimation
ollowing Infarction Noninvasive Evaluation) and the
INCAVAS (Finnish Cardiovascular Study) studies and
heir primary results have been reported (1,11). In brief,
EFINE participants were enrolled from 6 Canadian hos-
itals between May 2001 and July 2004, and were consid-
red eligible if they had a confirmed MI and at least mild
eft ventricular dysfunction in the initial week after MI. The
22 REFINE participants underwent serial noninvasive risk
ssessment, including post-exercise TWA assessment with
he MMA method from a 20- to 30-min high-resolution
igital electrocardiographic (ECG) recording. The final
3-month) assessment in the REFINE study was found to
rovide the most prognostic information (1) and was used in
his analysis. Participants of the FINCAVAS study were
nrolled from a consecutive series of patients undergoing
linical exercise stress testing at Tampere University Hos-
ital between October 2001 and December 2004. A total of
,103 patients were enrolled. Of these, 681 (32%) had a
istory of CAD. These 681 patients were used to provide a
opulation of patients with CAD in whom we could
alidate the results obtained in the REFINE population.
utcomes. Adjudicated outcome data were available for
oth cohorts. Outcomes were assessed independent of
WA results. We assessed CVD and all-cause mortality as
rinciple outcomes because of their unambiguous nature
19). Sudden death was assessed as a nonprinciple outcome
ue to the smaller number of events and challenges in
ategorizing deaths as arrhythmic versus nonarrhythmic.
ssessment of TWA. The MMA algorithm was used to
dentify and quantify TWA. The MMA algorithm sepa-
ates odd from even beats to allow direct comparison of their
verage morphologies. A series of beats, ranging from 16
weighting or update factor of 1/8) through 128 (weighting 1actor of 1/64), can be used. The
MA value is calculated for
very incoming beat. This results
n continual moving averages of
he odd and even beats. This ap-
roach has been demonstrated to
e intrinsically robust (17,20,21),
nd algorithms to reduce the influ-
nce of noise and respiratory arti-
act have been incorporated to en-
ance diagnostic accuracy (22).
ecause we sought in our analysis
o identify and validate cutpoints
n the immediate post-exercise pe-
iod, the highly accurate approach
sed in the FINCAVAS study
as used (no subtraction of noise
nd update factor of 1/8) (11).
est cohort (REFINE). The post-exercise assessment pe-
iod was selected as an optimal time point to implement the
MA method, because stress-induced TWA would be
etectable but surface noise and skeletal artifact could be
inimized (1). Three-month post-exercise data were avail-
ble for 306 of the 322 (95%) REFINE participants (1).
ata from the initial test period (initial month after MI)
ere used in the remaining 16 participants to provide a
omplete dataset (322 patients).
All REFINE participants underwent a submaximal exer-
ise treadmill assessment (target heart rate of 120 to 130
eats/min or 85% of the maximum predicted for age). A
igh-resolution (1,000 samples per second), 3-channel,
igital ECG recording (leads V1, V5, and Z) was obtained
t 2 to 3 min into the recovery stage. Recordings were
btained for 20 to 30 min to provide a series of sufficiently
ong windows free of artifact and ventricular ectopy to apply
he MMA method. Data were analyzed with the use of the
E Healthcare (Wauwatosa, Wisconsin), version 5.2,
MA algorithm, adapted from the method described by
earing and Verrier (17). The tracings were assessed with
he use of an automated system that identified TWA at any
oint during the recording. All identified TWA episodes
ere manually verified. The amplitude of the largest verified
MA voltage was recorded. No requirements for heart rate
r the duration of TWA were used because previous
esearch indicated that the MMA method appears to be less
eart rate dependent than the spectral TWA method (17).
alidation cohort (FINCAVAS). The FINCAVAS study
as designed to evaluate TWA assessment during exercise.
owever, post-exercise data also were available on all 681
articipants with CAD in the FINCAVAS study. The
ethod by which MMA data were collected has been
escribed previously (11). In brief, an upright bicycle was
sed and the workload increased from 20 to 30 W in a
tep-wise manner (10 to 30 W/min). Continuous digital
CGs were recorded at 500 Hz. A modified Mason-Likar
Abbreviations
and Acronyms
CAD  coronary artery
disease
CI  confidence interval
CVD  cardiovascular
death
EF  ejection fraction
HR  hazard ratio
IQR  interquartile range
MMA  modified moving
average
MI  myocardial infraction
ROC  receiver-operating
characteristic
TWA  T-wave alternans2-lead system was used. We calculated MMA continu-
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Post-Exercise Repolarization Alternans Assessment March 31, 2009:1130–7usly during the recovery period (3 to 6 min). For this
nalysis, MMA was calculated from all 12 leads and from a
imilar lead set as that used in the REFINE study (V1, V5,
nd aVF). Similar analytic methods to those described for
he REFINE cohort were used in the FINCAVAS study, as
as the same GE Healthcare version 5.2 MMA algorithm.
he FINCAVAS investigators performed an independent
nalysis of their post-exercise data by using the pre-
dentified cutpoints identified in the REFINE study before
ombining these datasets.
ombined data. After independent validation of the cut-
oints, data from the 2 cohorts were combined to provide a
ore reliable estimate of risk, to assess the linear relation-
hip between TWA voltage using the MMA method with
utcome, and to evaluate the prognostic utility of TWA
oltage using the MMA method versus EF as a continuous
easure in a large (n 1,000) population.
tatistical methods. Pairwise comparisons of continuous
nd categorical data between patients that did versus those
hat did not suffer CVD in each cohort were compared with
he use of the Wilcoxon rank sum and the Fisher exact test,
espectively. The capacity of TWA voltage, as assessed
sing the MMA method, to predict CVD and mortality was
ssessed with the use of Cox multivariate models from
hich hazard ratios (HRs) and 95% confidence intervals
CIs) were obtained. The proportional hazards assumption
as confirmed to be valid with the use of log-log plots and
ssessment of weighted residuals (23). Given the potential
mpact of age, sex, history of diabetes, heart rate, and
ignificant ischemia during exercise and EF, these variables
ere pre-specified to be included in the multivariate models.
ogistic regression models were used to calculate the area
nder the receiver-operating characteristic (ROC) curves.
he areas under ROC curves were compared with use of a
onparametric method (24). The time to development of
utcomes was graphically displayed by constructing Kaplan-
atient Characteristics
Table 1 Patient Characteristics
REFIN
No Cardiovascula
(n  302)
Median age, yrs (IQR) 62 (53–70)
Male (%) 85
History of diabetes (%) 21
History of hypertension (%) 45
Median QRS duration (IQR) 108 (100–11
Median ejection fraction (IQR) 0.48 (0.38–0
Beta-blocker (%) 94
ACE inhibitor or ARB (%) 90
Median resting heart rate, beats/min (IQR) 64 (57–71)
Peak exercise heart rate, beats/min (IQR) 114 (105–12
Heart rate when maximal TWA was observed, beats/min (IQR) 76 (69–88)
Significant ischemia with stress (%) 1
p  0.05 for comparison between those who did versus did not experience cardiac death in ea
INCAVAS participants.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker; FINCAVAS  Finnish Ca
oninvasive Evaluation; TWA  T-wave alternans.eier time to event curves, and differences in survival were
ssessed using the log-rank test statistic. A test for trend
cross ordered groups based on the Wilcoxon rank sum test
as used to assess the relationship of increasing TWA
oltage with outcome (25). Linear regression was used to
ssess the relationship between TWA voltage and EF. All
nalyses were performed with Stata 9.2MP (StataCorp LP,
ollege Station, Texas). Two-sided p values 0.05 were
onsidered significant.
esults
articipant characteristics. Characteristics of the 2 co-
orts, stratified by whether the participants did or did not
xperience CVD, are shown in Table 1. The median
ollow-up was 48 months (47 months in the REFINE and
8 months in the FINCAVAS study). In both cohorts, the
ajority of subjects were men and the median age of
articipants was 62 years. Approximately 20% of patients
ad a history of diabetes, and 45% had a history of
ypertension. Characteristics were similar in the 2 cohorts.
ll REFINE participants had their EF assessed at 8 to 10
eeks after MI. Ejection fraction data were available for 391
f the 681 FINCAVAS participants (57%). The median EF
n the REFINE study was 0.47, whereas the median EF in
he FINCAVAS study was 0.63.
linical outcomes. A total of 85 deaths (8.5%) were
bserved: 30 in the REFINE and 55 in the FINCAVAS
tudy. Of these, 54 (66%) were categorized as cardiovascular
5.4%): 20 in the REFINE and 34 in the FINCAVAS
tudy. A total of 35 deaths (17 in the REFINE and 18 in
he FINCAVAS study) were categorized as sudden.
haracteristics by outcome. Patients in the REFINE
tudy who suffered CVD were more likely to have a history
f diabetes and had lower median EF values compared with
atients in the REFINE study who did not suffer CVD in
ort (n  322) FINCAVAS Cohort (n  681)
h Cardiovascular Death
(n  20 [6%])
No Cardiovascular Death
(n  647)
Cardiovascular Death
(n  34 [5%])
62 (53–70) 62 (53–69) 69 (57–76)*
80 71 94*
35* 18 29
45 55 44
104 (96–114) 96 (90–104) 104 (98–102)*
0.38 (0.34–0.42)* 0.63 (0.55–0.72) 0.56 (0.42–0.66)*†
85 94 74
94 28 50*
67 (63–72) 62 (54–69) 61 (55–64)
110 (98–119) 138 (118–159) 121 (95–139)
78 (64–91) 93 (81–106) 89 (78–100)
0 20 38*
rt. †Ejection fraction data were available for all REFINE participants and 391 of the 681 (57%)E Coh
r Deat
6)
.56)
0)
ch cohordiovascular Study; IQR  interquartile range; REFINE  Risk Estimation Following Infarction,
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March 31, 2009:1130–7 Post-Exercise Repolarization Alternans Assessmentollow-up. Patients in the FINCAVAS study who suffered
VD were older, more likely to be men, had lower median
F values, and were more likely to have ischemia provoked
uring exercise testing compared with patients in the
INCAVAS study who did not experience CVD in follow-
p. Similar differences were observed for total mortality and
udden death.
ost-exercise versus stress phase. Both post-exercise and
tress data were available in the FINCAVAS study. The
edian noise level in the immediate post-exercise phase
hen the 3-lead set (5 V, interquartile range [IQR] 3 to 9
V) was used was lower than the median value observed
uring the stress phase (8 V, IQR 6 to 11 V) in the
INCAVAS study (p  0.001). Only post-exercise data
ere available for REFINE participants and a similar low
oise level was observed (median 3 V, IQR 2 to 6 V).
lthough both the stress and post-exercise periods provided
nformation on risk in the FINCAVAS study, the areas
nder the ROC curve for the 3-lead set tended to be larger
or the post-exercise versus stress phase data for all-cause
ortality (area 0.64 vs. 0.56; p  0.1) and CVD (area 0.67
s. 0.58; p  0.1).
utpoint identification (REFINE) and validation
FINCAVAS). CLINICAL OUTCOMES. Two MMA cut-
oints were identified in the REFINE study by evaluat-
ng the ROC data for CVD. One cutpoint provided high
ensitivity and modest positive accuracy (20 V), whereas
he other provided high specificity and greater positive
redictive accuracy (60 V). Both cutpoints were found
o be associated with similar test characteristics and
redictive value in the FINCAVAS cohort. Performance
f these cut-points in the cohorts individually and com-
ined are shown in Tables 2, 3, and 4.
ENSITIVE CUTPOINT. The 20-V cutpoint resulted in high
ensitivity in each cohort. The combined sensitivity was
7% for CVD. The positive accuracy for predicting CVD
ith this cutpoint was modest (7% combined) and the
egative accuracy was very high (98% combined). Similar
esults were observed for total mortality (Table 2).
PECIFIC CUTPOINT. The 60-V cutpoint resulted in high
redictive Value for the 20 V Cutpoint
Table 2 Predictive Value for the 20 V Cutpoint
Sensitivity Specificity
Positive
Accuracy
Negative
Accuracy
Cardiovascular death
REFINE 80 (76–84) 46 (41–51) 9 (6–12) 97 (95–99)
FINCAVAS 91 (89–93) 31 (27–34) 6 (5–8) 99 (98–99)
Combined 87 (85–89) 36 (33–39) 7 (6–9) 98 (97–99)
Total mortality
REFINE 73 (69–78) 46 (41–52) 12 (9–16) 94 (92–97)
FINCAVAS 87 (85–90) 31 (28–35) 10 (8–12) 97 (95–98)
Combined 82 (80–85) 36 (33–39) 11 (9–13) 96 (94–97)
alues are shown as mean percentage (95% confidence interval).
Abbreviations as in Table 1.pecificity in each cohort. The combined specificity was 95%
Vor CVD. The positive accuracy associated with this cut-
oint was 2-fold larger than the 20-V cutpoint (14%
ombined), whereas the negative accuracy remained high
95% combined). Similar results were observed for total
ortality (Table 3).
ISK OF SERIOUS OUTCOMES. The 20- and 60-V cutpoints
ach predicted a greater risk of CVD and all-cause mortality
n the REFINE and FINCAVAS cohorts individually
Table 4). The sensitive (20 V) cutpoint was associated
ith a 2.5-fold greater risk of CVD in the cohorts com-
ined. Similar results were observed when potential con-
ounding variables were adjusted for, including heart rate,
schemia, and EF. The specific (60 V) cutpoint was
ssociated with a 3.4-fold greater risk of CVD in the
ohorts combined. This relationship remained significant
espite multivariate adjustment. Similar results were ob-
erved for total mortality. The 20-V cutpoint tended to
e associated with a greater risk of sudden death before
HR: 1.83, 95% CI: 0.9 to 3.9; p  0.1) and after
djustment for the variables shown in Table 4 (HR: 2.0,
5% CI: 1.0 to 3.5; p  0.06), whereas the 60 V cutpoint
as associated with a significant, 3.1-fold (95% CI: 1.3 to
.4; p  0.01) greater risk of sudden death before and a
.6-fold (95% CI: 1.0 to 6.6; p  0.05) greater risk of
udden death after adjustment. The time to development of
VD (Fig. 1, left) and mortality (Fig. 1, right) in the
ohorts combined is shown in Figure 1. Patients with the
WA voltages 60 V had the greatest incidence of CVD
nd total mortality, whereas those with voltages of 20 to 59
V had an intermediate risk of these outcomes. These
MA cutpoints of 20 to 59 V and 60 V clearly
iscriminated among patients who did and did not suffer
VD (log-rank p  0.0001). These cutpoints also clearly
iscriminated among patients who died from any cause
ersus survived (log-rank p  0.0005).
inear relationship between TWA voltage and out-
ome. As a continuous variable, increasing TWA voltage,
s assessed with the MMA method in the immediate
ost-exercise period, was associated with a greater risk of
VD (HR: 1.05 per 5 V; 95% CI: 1.02 to 1.09; p 
.004) and mortality (HR: 1.04 per 5 V; 95% CI: 1.01 to
redictive Value for the 60 V Cutpoint
Table 3 Predictive Value for the 60 V Cutpoint
Sensitivity Specificity
Positive
Accuracy
Negative
Accuracy
Cardiovascular death
REFINE 20 (16–24) 92 (89–95) 14 (10–18) 95 (92–97)
FINCAVAS 12 (9–14) 96 (94–97) 13 (10–15) 95 (94–97)
Combined 15 (13–17) 95 (93–96) 14 (11–16) 95 (94–96)
Total mortality
REFINE 17 (12–21) 92 (89–95) 18 (14–22) 92 (89–94)
FINCAVAS 11 (9–13) 96 (95–97) 19 (16–22) 93 (91–94)
Combined 12 (11–15) 95 (93–96) 19 (16–21) 92 (91–94)alues are shown as mean percentage (95% confidence interval).
Abbreviations as in Table 1.
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Post-Exercise Repolarization Alternans Assessment March 31, 2009:1130–7.08; p  0.01) in the cohorts combined. Similar results
ere observed in each cohort. A clear relationship between
he rate of mortality (trend p  0.002) and the rate of CVD
trend p  0.0001) was observed (Fig. 2).
eart rate, ischemia, and beta-blockade. Given the po-
ential influence of heart rate, ischemia, and beta-blocker
herapy on the relationship of TWA value with the clinical
utcomes, these variables were evaluated. The median heart
ate when the maximal TWA value was observed was 82
IQR 62 to 100) beats/min in the cohorts combined. A
eak linear relationship between maximal TWA MMA
oltage and the heart rate when this value was recorded was
bserved (r2  0.005; p  0.02). However, no significant
ssociation between the heart rate when the maximal
ost-exercise TWA value was recorded and mortality (HR:
.94 per 10 beats/min increase, 95% CI: 0.84 to 1.05; p 
.27) or CVD (HR: 0.91 per 10 beat/min increase, 95% CI:
.80 to 1.05; p  0.20) was observed. The heart rate when
he maximal TWA value was recorded did not alter the
ssociation between increasing TWA MMA amplitude, as a
nadjusted and Adjusted Hazard Ratio Values for the Sensitive (20
Table 4 Unadjusted and Adjusted Hazard Ratio Values for the S
REFINE
(n  322)
FINCA
(n  6
Cardiovascular death, number of events 20 34
20 V 2.9 (1.2–7.4), 0.02 4.1 (1.3–13
60 V 3.7 (1.4–9.7), 0.008 2.8 (1.0–8.1
Total mortality, number of events 30 55
20 V 2.0 (1.0–4.0), 0.05 2.2 (1.3–3.9
60 V 2.4 (1.0–5.6), 0.04 2.6 (1.1–6.0
alues are hazard ratio (95% confidence interval), p value unless otherwise indicated. *Partially adj
jection fraction, the presence of ischemia, and heart rate when TWA was recorded.
Abbreviations as in Table 1.
Figure 1 Kaplan-Meier Incidence Curves for Cardiovascular Dea
Kaplan-Meier incidence curves for cardiovascular death (left) and total mortality (r
moving average (MMA) method of 60 V (green), 20 to 59 V (red), and 2
Patients with the greatest values had the greatest risk. Numbers of patients aontinuous variable, and an increased risk of mortality
adjusted HR: 1.04, 95% CI: 1.01 to 1.08; p  0.01) or
VD (adjusted HR: 1.05, 95% CI: 1.02 to 1.09; p 
.002).
A total of 143 patients, 3 in the REFINE and 140 in the
INCAVAS study, had evidence of ischemia on the exer-
ise test immediately preceding the post-exercise TWA
MA assessment (Table 1). The presence versus absence of
schemia was associated with a trend toward a greater risk of
ortality (HR: 1.7, 95% CI: 1.0 to 2.7; p 0.06) and CVD
HR: 1.7, 95% CI: 0.9 to 3.1; p 0.1), but adjusting for the
resence of ischemia on the exercise test did not alter the
elationship between increasing TWA MMA amplitude
nd the risk of mortality (adjusted HR: 1.03; p  0.03) or
VD (adjusted HR: 1.04; p  0.01).
In the REFINE study, beta-blockers were held imme-
iately before the exercise test, whereas in the FINCA-
AS study these agents were either continued or held 1
o 2 days before the exercise test. Beta-blocker use versus
onuse was not associated with an increased risk of
and Specific (60 V) Cutpoints
tive (20 V) and Specific (60 V) Cutpoints
Combined
(n  1,003)
Partially Adjusted*
(n  1,003)
Fully Adjusted†
(n  713)
54 54 40
2 2.5 (1.3–4.9), 0.007 2.4 (1.2–4.7), 0.01 2.5 (1.2–6.1), 0.01
3.4 (1.7–6.8), 0.0001 2.9 (1.4–5.7), 0.003 2.5 (1.1–6.0), 0.02
85 85 63
6 2.3 (1.4–3.6), 0.0001 2.0 (1.3–3.2), 0.03 1.9 (1.1–3.3), 0.02
2.9 (1.4–5.8), 0.003 2.5 (1.2–5.0), 0.01 2.4 (1.2–4.9), 0.01
odel includes age, sex, and history of diabetes. †Fully adjusted model also includes left ventricular
d Total Mortality
The risk of these outcomes in patients with T-wave alternans using the modified
(blue) significantly differed. The log-rank p values are shown on each graph.
n each time period are indicated at the bottom of each graph.V)
ensi
VAS
81)
.5), 0.0
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March 31, 2009:1130–7 Post-Exercise Repolarization Alternans Assessmentortality (HR: 1.3, 95% CI: 0.7 to 2.4; p  0.4) or CVD
HR: 2.0, 95% CI: 0.8 to 4.9; p  0.2) and did not alter
he relationship between increasing MMA amplitude and
he risk of mortality (adjusted HR: 1.04; p  0.01) or
VD (adjusted HR: 1.05; p  0.003). Adjustment for
he presence of significant ischemia, heart rate when the
aximal TWA value was recorded, EF, and other vari-
bles did not significantly alter the utility of the cutpoints
Table 3).
rognostic value of MMA voltage versus EF. The prog-
ostic value of TWA voltage, as a continuous variable,
as similar to EF, as a continuous variable, for the
utcome of CVD (each area under the ROC curve 0.69)
Fig. 3). Likewise, TWA voltage and EF, as continuous
ariables, similarly predicted the risk of mortality (each
rea under the ROC curve 0.67). Only a weak linear
elationship between TWA voltage and EF (r2  0.005;
 0.04) was identified.
ncremental prognostic information of the TWA cut-
oints. Both TWA cutpoints were independently associ-
ted with a greater risk of CVD and all-cause mortality after
djustment for important clinical variables (Table 3). Fur-
her, the areas under the ROC curve were larger when the
WA cutpoints were added to clinical variables that in-
luded age, sex, history of diabetes, EF, and heart rate
ROC areas of 0.70 for CVD and 0.67 for mortality,
ncluding the TWA cutpoints, versus ROC areas of 0.65 for
VD and 0.62 for mortality, including only the clinical
ariables). In fact, the TWA cutpoints provided substan-
ially more information on risk than did the individual
linical variables (p  0.001 for CVD and p  0.004 for
Figure 2 4-Year Incidence Rates of Cardiovascular Death
and Total Mortality by Quintile of TWA Voltage
Rates of cardiovascular death (orange) and total mortality (blue) at 4 years, by
quintile of T-wave alternans (TWA) using the modified moving average (MMA)
method.ortality when the ROC areas were compared).iscussion
his analysis demonstrates that post-exercise assessment of
WA with use of the MMA method is a strong, indepen-
ent predictor of CVD and total mortality in patients with
AD. A linear relationship was documented, with risk
ncreasing as TWA voltage increased. When assessed as a
ontinuous parameter, TWA voltage had similar predictive
tility as EF. Patients with increased TWA values had a
.5-fold greater risk of CVD independent of other impor-
ant variables, including EF, the presence of significant
schemia, and the heart rate when peak TWA was observed.
epolarization alternans assessment. Previous studies
ave demonstrated that TWA assessment can be used to
redict serious outcomes in patients with CAD and/or
ardiomyopathy. Many have used the spectral method (26).
wo studies have directly compared the spectral and MMA
WA methods in the same patients at the same time. Both
valuated MMA in a setting in which noise was minimized.
ox et al. (27) used atrial pacing, whereas the REFINE
nvestigators (1) used the post-exercise period. Both found
imilar predictive value with the spectral and MMA TWA
ethods in these low noise settings. Although a negative
pectral TWA test has been shown to predict a low risk of
erious events in most analyses (1,26,28,29), it has low
redictive accuracy in patients with CAD, making it less
ttractive for risk assessment as a single test (1,26,28). The
MA method (20,30) has been used in a variety of settings
exercise, post-exercise, atrial pacing, and/or ambulatory
CG) and is shown to predict a greater risk of serious
utcomes in each (1,11,18,27). However, the varying cut-
oints used in these studies have limited the clinical appli-
ation of this TWA assessment method.
Figure 3 ROC Curves for TWA MMA
Voltage and Ejection Fraction
Receiver-operating characteristic (ROC) curves for T-wave alternans (TWA) volt-
age using the modified moving average (MMA) method (orange) and left ven-
tricular ejection fraction (purple) are shown for the outcome of cardiovascular
death. The area under the ROC for TWA using the MMA method and ejection
fraction was 0.69.
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Post-Exercise Repolarization Alternans Assessment March 31, 2009:1130–7ost-exercise repolarization alternans assessment. The
mmediate post-exercise period appears to be an optimal
ime to implement the MMA method because it strikes a
alance between observing stress-induced changes in repo-
arization while minimizing associated noise and artifact.
ow noise levels were observed in both the REFINE and
INCAVAS cohorts during the post-exercise phase. This
nalysis demonstrates that post-exercise assessment of
WA by use of the MMA method is a reliable way to
dentify patients with CAD at risk of serious outcomes.
hese results were observed despite differences in the
opulations. Patients in the REFINE study had survived
recent MI, had testing performed early post-MI, and
ad median EF values of 0.47, whereas patients in the
INCAVAS study had established CAD, a clinical indica-
ion for exercise stress testing, and a median EF of 0.63. On
he basis of this analysis, post-exercise MMA assessment
ppears to be widely applicable in patients with CAD.
reater risk with increasing TWA voltage: clinical im-
lications. There is benefit to using a quantitative measure
f TWA versus a binary one. Larger TWA values are
nown to predict a greater risk of serious outcomes versus
ower values (31,32). This analysis extends these findings by
emonstrating a linear relationship between TWA magni-
ude and risk. Using TWA magnitude as a continuous value
o predict risk may be ideal, but additional work is required
o develop a robust strategy to accomplish this. Until this is
chieved, the use of validated cutpoints that can be applied
o a given patient appears warranted. The 20-V MMA
utpoint provides a sensitive marker of risk, so is likely to be
ost applicable in settings where patient risk is already
levated as the result of abnormalities in other parameters
uch as heart rate turbulence or baroreflex sensitivity (1). In
ontrast, the 60-V MMA cutpoint is a more specific
arker of risk and may be better suited for use in a low-risk
opulation, where TWA assessment is used as a single
creening test (11).
tudy limitations. Although this analysis indicates that
WA assessed in the immediate post-exercise period using
he MMA method provides important prognostic informa-
ion in patients with CAD, it is premature to extend our
bservations to other groups. Additional prospective valida-
ion of the MMA method is required, particularly data
elated to the exercise versus post-exercise phases. Data on
est-retest reproducibility of the MMA method, as well as
he spectral method, are required to determine whether
hanges in TWA over time are clinically meaningful (26).
urther, as with any observational study, it is not possible to
raw causal inferences and differences in variables that were
ot adjusted for or residual confounding may exist. Finally,
t is premature to make therapeutic recommendations based
n the results of TWA testing at this time. This holds true
or both the MMA method and the spectral method.
lthough each method has been independently associated
ith an increased risk of serious outcomes in this and othertudies, there have been no prospective randomized trials toonfirm that using TWA to decide on choice of therapy
lters patient outcome. This fact is highlighted by the
ASTER I (Microvolt T-Wave Alternans Testing for
isk Stratification of Post-Myocardial Infarction Patients)
rial, where a similar rate of appropriate defibrillator thera-
ies in patients with non-negative versus negative spectral
WA results was found (33).
onclusions
ost-exercise MMA is a strong, independent predictor of
VD and mortality in patients with CAD. The greater the
WA value, the greater the risk. To facilitate clinical
pplication of the MMA method, 2 cutpoints were identi-
ed, 1 sensitive (20 V) and 1 specific (60 V). Although
oth cutpoints independently predicted a greater risk of
VD and all-cause mortality, the use of one or the other in
given patient will depend on the setting in which the
WA assessment is used. The sensitive 20-V MMA
utpoint appears most applicable in patients already thought
o be at greater risk, whereas the specific 60-V MMA
utpoint appears best suited when TWA is used as a single
est in a lower-risk population.
eprint requests and correspondence: Dr. Derek V. Exner, 3330
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